Image

A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

Testing IDE161 for advanced solid tumors in a clinical study.

Recruiting
18 years and older
All
Phase 1

This study is testing a new drug called IDE161 for people with advanced solid tumors. Tumors are lumps or masses of abnormal cells. The study checks if the drug is safe, how well it works, and how the body processes it. Participants need to have specific genetic changes in their tumors, which make them suitable for this study. These changes affect how cells repair themselves, known as the homologous recombination (HR) pathway. People who join must be 18 or older, have tumors that are advanced or spread, and have tried other treatments first.

  • The study may involve multiple visits to the clinic for tests and check-ups.
  • Participants need to stop certain treatments before joining the study.
  • Compensation is not specified, but you should discuss this with the study team.
Study details
    Advanced or Metastatic Solid Tumors
    Breast Cancer
    Ovarian Cancer
    Prostate Cancer
    Endometrial Cancer
    Colorectal Cancer
    Head and Neck Cancers
    Nsclc

NCT05787587

IDEAYA Biosciences

15 March 2025

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.